SJADVA
DEAD

Serial Number

79344571

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 18, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SJADVA Trademark

Serial Number: 79344571 • Registration: 7117390

SJADVA is a trademark filed by NOVARTIS AG on May 18, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 18, 2022

Registration Date

July 25, 2023

Published for Opposition

May 9, 2023

Cancellation Date

October 2, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jul 8, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jul 8, 2025 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 12, 2023 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Oct 26, 2023 FICS
FINAL DISPOSITION PROCESSED
Oct 26, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 25, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 25, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 25, 2023 R.PR
NOTIFICATION PROCESSED BY IB
May 16, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 9, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 9, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 19, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 19, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 19, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 4, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 4, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 30, 2023 ERSI
REFUSAL PROCESSED BY IB
Jan 9, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 15, 2022 RFCS
REFUSAL PROCESSED BY MPU
Dec 15, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 4, 2022 RFCR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 3, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 3, 2022 GNSL
SUSPENSION LETTER WRITTEN
Oct 3, 2022 CNSL
ASSIGNED TO EXAMINER
Oct 3, 2022 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 12, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 12, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 12, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 12, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 12, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 12, 2022 COAR
APPLICATION FILING RECEIPT MAILED
Jul 19, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 13, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 12, 2022 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 7, 2022 SDRC